Skip to main content


Page 31 of 35

  1. Persons with schizophrenia and other psychotic disorders have a high prevalence of obesity, impaired glucose tolerance, and lipid abnormalities, particularly hypertriglyceridemia and low high-density lipoprote...

    Authors: Matej Orešič, Jing Tang, Tuulikki Seppänen-Laakso, Ismo Mattila, Suoma E Saarni, Samuli I Saarni, Jouko Lönnqvist, Marko Sysi-Aho, Tuulia Hyötyläinen, Jonna Perälä and Jaana Suvisaari
    Citation: Genome Medicine 2011 3:19
  2. Plausible genome-wide associations for episodic neurological diseases (such as migraine, epilepsy and ataxias) have been slow to emerge. The first such association was reported in a recent genome-wide associat...

    Authors: Verneri Anttila, Maija Wessman, Mikko Kallela and Aarno Palotie
    Citation: Genome Medicine 2011 3:17
  3. The rapid and continuing progress in gene discovery for complex diseases is fueling interest in the potential application of genetic risk models for clinical and public health practice. The number of studies a...

    Authors: A Cecile JW Janssens, John PA Ioannidis, Cornelia M van Duijn, Julian Little and Muin J Khoury
    Citation: Genome Medicine 2011 3:16
  4. The gut microbiome is the term given to describe the vast collection of symbiotic microorganisms in the human gastrointestinal system and their collective interacting genomes. Recent studies have suggested tha...

    Authors: James M Kinross, Ara W Darzi and Jeremy K Nicholson
    Citation: Genome Medicine 2011 3:14
  5. There has been considerable interest in cancer stem cells (CSCs) among cancer biologists and clinicians, most likely because of their role in the heterogeneity of cancer and their potential application in canc...

    Authors: Bo Wang and Samson T Jacob
    Citation: Genome Medicine 2011 3:11
  6. The risk of certain birth defects can be modified by maternal diet. A high-fat maternal mouse diet has recently been reported to substantially increase the penetrance of birth defects known to be associated wi...

    Authors: Krista S Crider and Lynn B Bailey
    Citation: Genome Medicine 2011 3:9
  7. Chronic hepatitis C virus (HCV) infection is a major cause of liver disease worldwide. HCV infection is currently treated with IFNα plus ribavirin for 24 to 48 weeks. This demanding therapy fails in up to 50% ...

    Authors: John E Tavis, Maureen J Donlin, Rajeev Aurora, Xiaofeng Fan and Adrian M Di Bisceglie
    Citation: Genome Medicine 2011 3:8
  8. Three recent genome-wide association studies of testicular germ cell tumors have uncovered predisposition alleles in or near several genes, including KITLG, BAK1, SPRY4, TERT, ATF7IP, and DMRT1. The calculated pe...

    Authors: Christian P Kratz, Gennady Bratslavsky and Jianxin Shi
    Citation: Genome Medicine 2011 3:1
  9. Multiple sclerosis (MS) is the most common cause of chronic neurologic disability beginning in early to middle adult life. Results from recent genome-wide association studies (GWAS) have substantially lengthen...

    Authors: Joanne H Wang, Derek Pappas, Philip L De Jager, Daniel Pelletier, Paul IW de Bakker, Ludwig Kappos, Chris H Polman, Lori B Chibnik, David A Hafler, Paul M Matthews, Stephen L Hauser, Sergio E Baranzini and Jorge R Oksenberg
    Citation: Genome Medicine 2011 3:3
  10. Cell type heterogeneity may have a substantial effect on gene expression profiling of human tissue. Several in silico methods for deconvoluting a gene expression profile into cell-type-specific subprofiles have b...

    Authors: Yingdong Zhao and Richard Simon
    Citation: Genome Medicine 2010 2:93
  11. Cystic fibrosis is one of the most common life-limiting inherited disorders. Its clinical impact manifests chiefly in the lung, pancreas, gastrointestinal tract and sweat glands, with lung disease typically be...

    Authors: Sally H Pattison and J Stuart Elborn
    Citation: Genome Medicine 2010 2:88
  12. Sudden infant death syndrome (SIDS) is a major contributor to postneonatal infant death, and is the third leading cause of infant mortality in the USA. While public health efforts have reduced these deaths in ...

    Authors: David W Van Norstrand and Michael J Ackerman
    Citation: Genome Medicine 2010 2:86
  13. Imatinib mesylate (IM), a tyrosine kinase inhibitor, is one of the first molecularly targeted therapies to have been used in the clinic. It has proven to be efficient in the treatment of chronic myeloid leukem...

    Authors: Stéphanie Dulucq and Maja Krajinovic
    Citation: Genome Medicine 2010 2:85
  14. A recent publication that combined rat gene expression data and a human genetic association study has identified the first genetic risk factor for chronic pain in humans. In four of the five cohorts studied, t...

    Authors: Ming Zheng and Gary Peltz
    Citation: Genome Medicine 2010 2:82
  15. Discoveries from genome-wide association studies have contributed to our knowledge of the genetic etiology of many complex diseases. However, these account for only a small fraction of each disease's heritabil...

    Authors: Nadine Melhem and Bernie Devlin
    Citation: Genome Medicine 2010 2:79
  16. Endometriosis is a gynecological disease characterized by implantation of endometrial tissue outside of the uterus. Early familial aggregation and twin studies noted a higher risk of endometriosis among relati...

    Authors: Erica C Dun, Robert N Taylor and Fritz Wieser
    Citation: Genome Medicine 2010 2:75
  17. A correction to: Bonnie R Joubert, Ethan M Lange, Nora Franceschini, Victor Mwapasa, Kari E North, Steven R Meshnick andthe NIAID Center for HIV/AIDS Vaccine Immunology. A whole genome association study of mother...

    Authors: Bonnie R Joubert, Ethan M Lange, Nora Franceschini, Victor Mwapasa, Kari E North and Steven R Meshnick
    Citation: Genome Medicine 2010 2:76

    The original article was published in Genome Medicine 2010 2:17

  18. Preimplantation genetic diagnosis (PGD) involves testing of single cells biopsied from oocytes and/or embryos generated in vitro. As only embryos unaffected for a given genetic condition are transferred to the ut...

    Authors: Martine De Rycke
    Citation: Genome Medicine 2010 2:74
  19. Stem cell banks are increasingly seen as an essential resource of biological materials for both basic and translational research. Stem cell banks support transnational access to quality-controlled and ethicall...

    Authors: Bartha M Knoppers and Rosario Isasi
    Citation: Genome Medicine 2010 2:73
  20. Eosinophilic esophagitis (EoE) is increasingly diagnosed as a disorder throughout the world. It is characterized by eosinophils in the esophagus due to food allergies. Molecular analysis of esophageal biopsies...

    Authors: Jonathan M Spergel
    Citation: Genome Medicine 2010 2:60
  • Editorial Board
  • Editorial Team
  • Call for EBMs
  • Call for papers
  • Sign up for article alerts and news from this journal
  • Manuscript editing services
  • Contact us
  • Announcements

    C19 Rapid Review initiative

    Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.

Annual Journal Metrics

  • 2022 Citation Impact
    12.3 - 2-year Impact Factor
    13.8 - 5-year Impact Factor
    2.422 - SNIP (Source Normalized Impact per Paper)
    4.851 - SJR (SCImago Journal Rank)

    2022 Speed
    64 days submission to first editorial decision for all manuscripts (Median)
    212 days submission to accept (Median)

    2022 Usage 
    14,220 Altmetric mentions